Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Rheumatoid Arthritis
NCT05790356Recruiting
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Fecal Microbial Transplant with Placebo (2 arms). Primary endpoints: Change in Intestinal Permeability at 6 weeks, Change in RA-associated autoantibodies at 12 weeks and 1 more. Started Aug 2023; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05790356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05790356.